Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H)

AD Kirk, DA Hale, RB Mannon, DE Kleiner… - …, 2003 - journals.lww.com
AD Kirk, DA Hale, RB Mannon, DE Kleiner, SC Hoffmann, RL Kampen, LK Cendales…
Transplantation, 2003•journals.lww.com
RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUAT... :
Transplantation RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL
EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB
(CAMPATH-1H) : Transplantation Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe
Register Login Articles & Issues Editor's Picks Collections Social Media For Authors Journal Info …
RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H): Transplantation
Lippincott Williams & Wilkins
Show moreShow less
Save Cite Cited by 513 Related articles All 7 versions